Qrons licenses 3D printing tech from Dartmouth Uni
15-10-2019
United Therapeutics signs 3D bioprinting technology deal
23-10-2018
01-08-2023
Scharfsinn / Shutterstock.com
Amid worldwide interest, India could position itself as a global hub for a desperately needed technology, say Kavita Arora and Shaivya Dhawan of K&S Partners.
The shortage of organ donors and the resulting loss of lives due to tissue damage or organ failure is a global crisis. In India, approximately 500,000 people die annually due to the lack of an organ donor.
In the US, over 104,000 people were on the national transplant waiting list as of June 2023. Regenerative medicine and tissue engineering is a promising breakthrough with the potential to save lives, and perhaps revolutionise the healthcare and pharmaceutical industries.
3D bioprinting: A new frontier
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
India, bioprinting, 3d printing, additive manufacturing, organ transplants, tissue engineering, ex vivo liver regeneration